Alpine Global Management’s Mersana Therapeutics MRSN Stock Holding History

Alpine Global Management’s Portfolio MRSN Stock Details MRSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-401	Closed	-$40	–	598
2022 Q1	$40	Sell	401 -233	-37%	-$27.2K	0.01%	321
2021 Q4	$99K	Buy	+634	New	+$123K	0.01%	644
2021 Q2	–	Sell	-426	Closed	-$172K	–	344
2021 Q1	$172K	Buy	+426	New	+$207K	0.02%	260

Other funds holding MRSN

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return